A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 62
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FC
Long Form : formocresol
No. Year Title Co-occurring Abbreviation
2019 A histopathological comparison of pulpal response to formocresol and sodium hypochlorite used as pulpotomy medicaments: In primary teeth - A clinical trialA histopathological comparison of pulpal response to formocresol and sodium hypochlorite used as pulpotomy medicaments: In primary teeth - A clinical trial. ---
2019 Clinical and Radiographic Evaluation of Allium sativum Oil (Garlic Oil) in Comparison with Formocresol in Primary Molar Pulpotomy. ---
2019 Ferric Sulfate and Formocresol pulpotomies in paediatric dental practice. A prospective-retrospective study. FS, GIC, SSC, VPT
2019 Success rates of mineral trioxide aggregate, ferric sulfate, and sodium hypochlorite pulpotomies: A prospective 24-month study. FS, IPT, MTA
2019 The Clinical Effectiveness of Calcium Hydroxide in Root Canal Disinfection of Primary Teeth: A Meta-Analysis. CI, CP, EIAE, PICO
2018 Evaluation of Four Pulpotomy Techniques in Primary Molars: A Randomized Controlled Trial. CEM, FS, LLLT
2017 Clinical and Radiographic Evaluation of Four Different Pulpotomy Agents in Primary Molars: A Longitudinal Study. EMD, MTA
2017 Clinical and radiographic evaluation of white MTA versus formocresol pulpotomy: A 48-month follow-up study. MTA
2017 Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. ABS, FS
10  2017 Evaluation and Comparison between Formocresol and Sodium Hypochlorite as Pulpotomy Medicament: A Randomized Study. ---
11  2017 Primary Tooth Vital Pulp Therapy: A Systematic Review and Meta-analysis. CH, DPC, FS, IPT, MTA, RoB, VPT
12  2016 Clinical Pulpotomy Trial of Copaifera Langsdorffii Oil Resin Versus Formocresol and White Mineral Trioxide Aggregate in Primary Teeth. CLOR, WMTA
13  2016 Immunolocalization of dentin matrix protein-1 in human primary teeth treated with different pulp capping materials. CH, DMP, MTA, PC
14  2015 Antimicrobial activity of filling materials used in primary teeth pulpotomy. CH, MTA, ZOE, ZOEFC
15  2015 Clinical and radiographic outcomes of the use of Low-Level Laser Therapy in vital pulp of primary teeth. CH, LLLT
16  2015 Comparative evaluation of pro-inflammatory cytokine levels in pulpotomized primary molars. CH, ELISA, IL, MExp, MTA
17  2015 Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. MTA
18  2015 Sodium Hypochlorite Versus Formocresol and Ferric Sulfate Pulpotomies in Primary Molars: 18-month Follow-up. FS
19  2014 A tunnel shape defect on maxillary bone after accidental injection of formocresol instead of anesthetic solution. ---
20  2014 Clinical and radiographic success of mineral trioxide aggregate compared with formocresol as a pulpotomy treatment in primary molars: a systematic review and meta-analysis. CI, MTA, RCTs, RR
21  2014 Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study. MTA
22  2014 In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate. DL, FS
23  2014 No clear evidence of superiority regarding pulp medicaments in primary molars. CENTRAL, CH, FS, MTA, WHO
24  2014 Pulp treatment for extensive decay in primary teeth. CENTRAL, CH, FS, MTA, WHO
25  2013 Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up. MTA
26  2013 Sodium hypochlorite versus Formocresol in primary molars pulpotomies: a randomized clinical trial. SSC
27  2013 Sodium hypochlorite vs formocresol as pulpotomy medicaments in primary molars: 1-year follow-up. ---
28  2012 Biodentine used as a pulp-capping agent in primary pig teeth. WMTA
29  2012 Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up. MTA
30  2012 Effects of folk medicinal plant extract Ankaferd Blood Stopper() in vital primary molar pulpotomy. ABS
31  2012 Nigella sativa oil as a pulp medicament for pulpotomized teeth: a histopathological evaluation. NS
32  2011 Comparison of three pulpotomy agents in primary molars: a randomised clinical trial. ES, FS
33  2011 Effects of mineral trioxide aggregate and formocresol on vital pulp after pulpotomy of primary molars: An in vivo study. MTA
34  2011 Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. FS, MTA
35  2010 Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. MTA
36  2010 Morphological and biochemical changes during formocresol induced cell death in murine peritoneal macrophages: apoptotic and necrotic features. PMO
37  2009 Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. MTA
38  2008 A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up. FS, MTA
39  2008 Ability of root canal antiseptics used in dental practice to induce chromosome aberrations in human dental pulp cells. CC, CMCP
40  2008 Beta-tricalcium phosphate, white mineral trioxide aggregate, white Portland cement, ferric sulfate, and formocresol used as pulpotomy agents in primary pig teeth. beta-TCP, FS, WMTA, WPC
41  2008 Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. EMD
42  2008 Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. MTA
43  2008 Comparison of pulpotomy with formocresol and MTA in primary molars: a systematic review and meta- analysis. MTA
44  2008 Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. ---
45  2008 Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment. CH, CORs, CTs, FS, MTA, RCTs
46  2008 The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. CH, MTA, ZOE
47  2007 Better outcomes in pulpotomies on primary molars with MTA. MTA
48  2007 Biocompatibility of various formula root filling materials for primary teeth. ANOVA, CPC, ZnO
49  2007 Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. MTA
50  2007 [The study of cytotoxicity of different intracanal medications and cell rehabilitation on human periodontal ligament fibroblasts]. ALP, CP, HPLFs, TEM
51  2006 Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. CI, MTA, RR
52  2005 Evaluation of three pulpotomy medicaments in primary teeth. Ca, FS
53  2005 Histological comparison of alendronate, calcium hydroxide and formocresol in amputated rat molar. ALN, CH
54  2005 Influence of zinc-oxide eugenol, formocresol, and ferric sulfate on bond strength of dentin adhesives to primary teeth. FS, SBS, ZOE
55  2005 Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. MTA
56  2005 Success of mineral trioxide aggregate in pulpotomized primary molars. MTA
57  2004 [Pulpotomy of deciduous teeth]. ZOE
58  2003 Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar. BAG, FS, MTA
59  2003 Influence on pH of vehicle containing glycerin used with calcium hydroxide. ---
60  2001 Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. MTA, ZOE
61  1990 [Histomorphometry of dentigerous cysts in children, associated or not with formocresol]. DC
62  1987 Mouse T-cell-dependent proliferative response to syngeneic serum modified with various agents used in root canal therapy. FC-MS